Le Lézard
Classified in: Environment, Health, Science and technology, Business
Subjects: JVN, TRI, ANW

Oxitec Successfully Concludes Mosquito Releases in Landmark Florida Keys Pilot Program


OXFORD, England, Nov. 24, 2021 /PRNewswire/ -- Oxitec today announced the successful completion of the mosquito release phase of its landmark project with the Florida Keys Mosquito Control District. All Oxitec mosquito boxes will be removed from participants' properties in the coming weeks. Monitoring of the project continuing into 2022.

The pilot project, which began in April 2021 with approvals from the US Environmental Protection Agency (EPA), Florida state, and local government, was designed to evaluate the use of Oxitec mosquitoes in controlling the invasive Aedes aegypti mosquitoes found in the Florida Keys and other regions of the United States.

Aedes aegypti can spread dengue, Zika, yellow fever, chikungunya, heartworm and other diseases. The Florida Keys has reported cases of dengue fever as recently as 2020, which emphasizes the importance of controlling these non-native mosquitoes.

Throughout the project, Oxitec's non-biting male mosquitoes successfully dispersed from small boxes as expected, mated with invasive pest females successfully, and produced male-only offspring, demonstrating the 100% larvicidal effectiveness of Oxitec's self-limiting technology.   

Public support for the pilot in the Florida Keys remains high. Outside of two large tropical storms, the project ran smoothly and according to plan with no interruptions.

Grey Frandsen, CEO of Oxitec, commented:

"We're delighted that our first mosquito releases on US soil have gone so well. We could not have done this without the ongoing and outstanding support of our partner, the Florida Keys Mosquito Control District, its board of directors, and its staff. We're also deeply thankful for the incredible support we've received from Keys residents, businesses, associations, public officials, scientists, students, and non-profits in the Keys who rallied around our team, our work, and our cause as their own. The success of this project is due entirely to this wonderfully broad and diverse group of stakeholders who share the belief that new, environmentally sustainable methods are needed to effectively control disease-spreading mosquitoes while protecting sensitive ecosystems. Excellent teamwork all around in this exemplar public-private collaboration."

This update comes after recent news of Oxitec's commercial launch of its Aedes aegypti technology in Brazil; it's new partnership with the Wellcome Trust to scale-up the use of its Aedes aegypti solution for global impact; and the deregulation of Oxitec's fall armyworm solution by Brazil's biosafety regulator, CTNBio.

To stay up to date or learn more about the Florida Keys project, please visit keysmosquitoproject.com.

About Oxitec

Oxitec is the leading developer of biological solutions to control pests that transmit disease, destroy crops and harm livestock. Founded in 2002 at the University of Oxford, Oxitec is led by a passionate team comprised of 15 nationalities and is supported by world-class partners. Learn more at oxitec.com.

SOURCE Oxitec


These press releases may also interest you

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...



News published on and distributed by: